174
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Substitution of aqua ligands from alkyldiamine-bridged dinuclear Pt(II) complexes using azole nucleophiles

, &
Pages 4280-4291 | Received 17 Jun 2013, Accepted 05 Nov 2013, Published online: 04 Dec 2013

References

  • (a) M. Gielen, E.R.T. Tiekink. Metallotherapeutic Drugs and Metal-based Diagnostic Agents, The Use of Metals in Medicine., Wiley and Sons Ltd., West Sussex, England (2005); (b) C.X. Zhang, S.J. Lippard. Curr. Opin. Chem. Biol., 7, 481 (2003); (c) E.R.T. Tiekink. Crit. Rev. Oncol. Hematol., 42, 225 (2002); (d) B. Sanna, M. Debidda, G. Pintus, B. Tadolini, A.M. Posadino, F. Bennardini, G. Sava, C. Ventura. Arch. Biochem. Biophys., 403, 209 (2002); (e) C.G. Hartinger, S. Zorbass-Seifried, M.A. Jakupec, B.K. Keppler. J. Inorg. Biochem., 100, 891 (2006); (f) C.G. Hartinger, M.A. Jakupec, S. Zorbass-Seifried, M. Groessla, A. Eggera, W. Bergerd, H. Zorbasc, P.J. Dyson, B.K. Keppler. Chem. Biodiversity, 5, 2140 (2008); (g) M. Rademasker-Lakhai, D. van Den Borgard, D. Pluim, J.H. Beijnen, J.H.M. Schellens. Clin. Cancer Res., 10, 3717 (2004); (h) A.L. Harris, J.J. Ryan, N. Farrell. Mol. Pharmacol., 69, 666 (2006); (i) J. Zehnulova, J. Kasparkova, N. Farrell, V. Brabec. J. Biol. Chem., 276, 2219 (2001); (j) G. Pratesi, P. Perego, D. Polizzi, S.C. Righetti, R. Supino, C. Caserini, C. Manzotti, F.C. Giuliani, G. Pezzoni, S.L. Tognella, S. Spinelli, N. Farrell, F. Zunino. Br. J. Cancer, 80, 1912 (1999); (k) D.B. Zamble, T. Jacks, S.J. Lippard. Proc. Natl. Acad. Sci., USA, 95, 6163 (1998).
  • J. Cairns. Cancer Science and Society, W.H. Freeman and Company, USA, 1, 35 (1978).
  • D.E. Thurston. Chemistry and Pharmacology of Anti-Cancer Drugs, CRC Press Taylor & Francis Group, USA, 1–27(61–63), 69–73 (2007).
  • J.E. Trosko, C.C. Chang, B.V. Madhukar, E. Dupont. New Frontiers in Cancer Causation, O.H. Iversen (Ed.), Taylor and Francis Publishers, Washington, DC. (1993).
  • G.N. Wogan, S.S. Hecht, J.S. Felton, A.H. Conney, L.A. Loeb. Sem. Cancer Biol., 14 (2004).
  • M. Pan, C. Ho. Chem. Soc. Rev., 37, (2008).
  • Y. Ho, S.F. Au-Yeung, K.W. To. Med. Res. Rev., 23, (2003).
  • World Health Organisation. Global Burden of Diseases Update World Health Organisation, 11, 21 (2008).
  • (a) M.D. Abeloff, J.O. Armitage, A.S. Lichter, J.E. Niederhuber. Cancer Management, Clinical Oncology, 2nd Edn., Churchill Livingstone, Inc., Philadelphia, PA (2000); (b) Principles of Cancer Therapy Surgery. In The Merck Manual of Diagnosis and Therapy,M.H. Beers and R. Berkow (Eds.), Merck Research Laboratories, Whitehouse Station, NJ (1999).
  • P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, M.A. Maiman, D.L. Clarke-Pearson, S. Insalako. The New England J. Med., 340, 1144 (1999).
  • B. Teni, P. Alexandros, B. Evagelos, C. Petros. Cancer Therapy, 5583, 53 (2007).
  • A. Sigel, H. Sigel. Metal Ions in Biological Systems, Marcel Dekker Inc., NY, 53 (1996).
  • F.R. Hartley. Chemistry of the Platinum Group Metals: Recent Developments, Elsevier, Amsterdam, 23, 547 (1991).
  • T.W. Hambley. Coord. Chem. Rev., 166, 181 (1997).
  • S. Sherman, D. Gibson, A. Wang, S. Lippard. Science, 230, 412 (1985).
  • R. Airley. Cancer Chemotherapy, Basic Science to the Clinic, Wiley-Blackwell, 67 (2009).
  • C.J. Jones, J. Thornback. Amer. J. Therapeutics, 592 (2007).
  • C. Orving, M.J. Abrams. Chem. Rev., 99, 2201 (1999).
  • I. Kostova. Recent Patents on Anti-Cancer Drug Discovery, 1, 1 (2006).
  • S.J. Lippard. Bioinorg. Chem., 246, 1 (1995).
  • K.M. Brière, R. Goel, F.H. Shirazi, D.J. Stewart, I.C.P. Smith. Cancer Chemotherapy Pharmacol., 37, 518 (1996).
  • F.A. Blommaert, H.C.M. Van Dijk-Knijnenberg, F.J. Dijt, L. den Engelse, R.A. Bann, F. Berends, A.M.J. Fichtinger-Schepman. Biochem., 34, (1995).
  • E. Wong, C.M. Giandomenico. Chem. Rev., 99, 2451 (1999).
  • US Food and Drug Administration Drug Fact Sheet, Eloxatin, 1 (2003).
  • L.S. Hollis. Platinum and Other Metal Coordination Compounds in Cancer, Chemotherapy, 115 (1991).
  • S.J. Lippard. Science, 261, 699 (1993).
  • J. Reedijk. Inorg. Chim. Acta, 198, 873 (1992).
  • G. Giaccone. Drugs, 59, 9 (2000).
  • D.H. Mathew, R.M. Howard, C. Richard, W.H. Trevor. J. Med. Chem., 50, 1 (2007).
  • J. Reedijk. Chem. Rev., 7, 361 (2003).
  • J. Reedijk. Platinum Metals Rev., 52, 1 (2008).
  • B.V. Petrovic, M.I. Djuran, D.Z. Bugarčić. Metal-Based Drugs, 6, 355 (1999).
  • A. Pasini, C. Fiore. Inorg. Chim. Acta, 285, 196 (1999).
  • A. Mambanda, D. Jaganyi, S. Hochreuther, R. van Eldik. Dalton Trans., 3595 (2010).
  • A. Mambanda, D. Jaganyi. Dalton Trans., 79 (2011).
  • M. Sato, T. Mori, T. Lida. Synthesis, 539 (1992).
  • A. Hofmann, R. van Eldik. Dalton Trans., 2979 (2003).
  • D.Z. Bugarčić, B.V. Petrovic, R. Jelic. Transition Met. Chem., 26, 638 (2001).
  • G. Mahal, R. van Eldik. Inorg. Chem., 24, 4165 (1985).
  • G. Mahal, R. van Eldik. Inorg. Chem., 127, 203 (1987).
  • Origin 7.5 SRO, v 7.571 (B714), Origin Lab Corporation, Northampton, MA (2003).
  • H. Erturk, A. Hofmann, R. Puchta, R. van Eldik. Dalton Trans., 2295 (2007).
  • Spartan 04, Wavefunction, Inc., 18401 von Karman Avenue, Suite 370, Irvine, CA, 92612, USA; Q-Chem. Inc., The Design Centre, Suite 690, 5001 Baum Blvd., Pittsburgh, PA 15213, USA (2004); http://www.wavefun.com.
  • Z. Chival, M. Sip, V. Burda. J. Comp. Chem., 29, 2370 (2008).
  • R. Katritzky, C.W. Rees. Comprehensive Heterocyclic Chemistry, 35(169), 734 (1984).
  • T. Eicher, S. Hauptmann. The Heterocyclic Chemistry, 165(179), 208 (2003).
  • B. Pitteri, M. Bortoluzzi. Polyhedron, 25, 2698 (2006).
  • D. Reddy, K.J. Akerman, M.P. Akerman, D. Jaganyi. Transition Met. Chem., 36, 593 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.